Cingulate Inc. (CING) Stock Forecast

NASDAQ: CINGAnalyst ratings, price target and estimates.

CING analyst forecast

as of October 18, 2026
Analyst consensus
Strong buy
4.75 / 5 from 4 analysts
Price target
$21.20
average of analyst targets
Upside to target
+386.2%
from the latest close
Next earnings
November 12, 2026
EPS estimate $-0.48
52-week range
$3.33 – $11.66

CING analyst ratings

4 analysts
Strong buy
375%
Buy
125%
Hold
00%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

CING price target

Price $4.36Target $21.20
52-week low $3.3352-week high $11.66

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

CING earnings per share estimates

Cingulate Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$0.45−$0.55−$0.39−$1.35+66.9%3
Current fiscal year (2026)−$2.19−$2.38−$2.04−$4.44+50.7%4
Next fiscal year (2027)−$0.88−$2.30$1.81−$2.19+59.8%4

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

CING revenue estimates

Cingulate Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$0$0$00.0%4
Current fiscal year (2026)$0$0$00.0%4
Next fiscal year (2027)$22.3M$0$74.8M0.0%5

CING EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

CING revenue: reported and forecast

Reported revenueEstimate (average; low–high)

CING EPS estimate revisions

Cingulate Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)−$0.67−$0.53−$0.53−$0.53−$0.45−33.0%2 up · 1 down
Current fiscal year (2026)−$2.63−$2.30−$2.30−$2.30−$2.19−16.8%2 up · 1 down
Next fiscal year (2027)−$1.92−$0.74−$0.74−$0.74−$0.88−54.0%1 up · 2 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

CING earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; CING beat in 5 of 12.

What analysts expect from CING

4 analysts cover Cingulate; their consensus rating is strong buy (4.75 on a 1–5 scale, where 5 is a strong buy). The average price target is $21.20, 386.2% above the latest close of $4.36. Analysts expect earnings of −$2.19 per share for 2026, +50.7% from a year earlier. For 2027 the average estimate is −$0.88 per share on revenue of $22.3 million. Cingulate beat the EPS estimate in 5 of the last 12 quarters.

Related: CING income statement, CING key metrics, CING chart. See the CING stock overview for the latest quote and news.

CING forecast FAQ

What is Cingulate's price target?

The average analyst price target for Cingulate is $21.20, 386.2% above the latest close of $4.36.

Is Cingulate a buy, hold or sell?

Of 4 analysts covering Cingulate, 3 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Cingulate's EPS forecast?

Analysts forecast −$2.19 per share for 2026 (range −$2.38 to −$2.04); for 2027 the estimate is −$0.88.

When does Cingulate report earnings?

Cingulate is expected to report results for the quarter ending September 30, 2026 on November 12, 2026; the EPS estimate is $-0.48.

Does Cingulate usually beat earnings estimates?

Cingulate reported EPS at or above the analyst estimate in 5 of the last 12 quarters.

Biotechnology: forecast